Check out this #Rareatives interview with our VP of Clinical Research, Chad Glasser! He discusses patient-informed #RareDisease trials, the recent #MELAS EL-PFDD meeting led by #MitoAction, and the completion of enrollment in our Ph2b PRIZM study. #Biosky rareatives.com/2026/04/29/t...
